• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Surgical Endoscopy >Robot-assisted laparoscopic pancreatic surgery: single-surgeon experience.
【24h】

Robot-assisted laparoscopic pancreatic surgery: single-surgeon experience.

机译：机器人辅助的腹腔镜胰腺手术：单手术经验。

获取原文
获取原文并翻译 | 示例
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: Use of robotic surgery has gained increasing acceptance over the last few years. There are few reports, however, on advanced pancreatic robotic surgery. In fact, the indication for robotic surgery in pancreatic disease has been controversial. This paper retrospectively reviews one surgeon's experience with robotic surgery to treat pancreatic disease, and analyzes its indications and outcomes, as well as the controversy that exists. METHODS: A retrospective review of the charts of all patients who underwent robotic surgery for pancreatic disease by a single surgeon at two different institutions was carried out. RESULTS: From October 2000 to January 2009, 134 patients underwent robotic-assisted surgery for different pancreatic pathologies. All procedures were performed using the da Vinci robotic system. Of the 134 patients, 83 were female. The average age of all patients was 57 years (range 24-86 years). Mean operating room (OR) time was 331 min (75-660 min). There were 14 conversions to open surgery. Mean length of stay was 9.3 days (3-85 days). Length of stay for patients with no complications was 7.9 days (3-15 days). The postoperative morbidity rate was 26% and the mortality rate was 2.23% (three patients). Among the procedures performed were 60 pancreaticoduodenectomies, 23 spleen-preserving distal pancreatectomies, 23 splenopancreatectomies, 3 middle pancreatectomies, 1 total pancreatectomy, and 3 enucleations. Another 21 patients underwent different surgical procedures for treatment of acute and chronic pancreatitis. Two cases of pancreaticoduodenectomy were performed in outside institutions and are not included in this series. CONCLUSIONS: This is the largest series of robotic pancreatic surgery presented to date. Robotic surgery enables difficult technical maneuvers to be performed that facilitate the success of pancreatic minimally invasive surgery. The results in this series demonstrate that it is feasible and safe. Complication and mortality rates are comparable to those of open surgery but with the advantages of minimally invasive surgery.
机译：背景：在过去的几年中，机器人手术的使用越来越受到人们的欢迎。但是，有关晚期胰腺机器人手术的报道很少。实际上，在胰腺疾病中进行机器人手术的适应症一直存在争议。本文回顾性地回顾了一位外科医生在机器人手术中治疗胰腺疾病的经验，并分析了它的适应症和预后以及存在的争议。方法：回顾性回顾了由一名外科医生在两个不同机构进行胰腺疾病机器人手术的所有患者的病历。结果：从2000年10月到2009年1月，有134例患者接受了针对不同胰腺疾病的机器人辅助手术。所有程序均使用da Vinci机器人系统执行。在134名患者中，有83名是女性。所有患者的平均年龄为57岁（范围24-86岁）。平均手术室（OR）时间为331分钟（75-660分钟）。有14项转换为开放手术。平均住院时间为9.3天（3-85天）。无并发症患者的住院时间为7.9天（3-15天）。 3例患者的术后发病率为26％，死亡率为2.23％。其中执行的手术包括60例胰十二指肠切除术，23例保留脾的远端胰切除术，23例脾脏胰切除术，3例中胰腺切除术，1例全胰腺切除术和3例摘除术。另外21例患者接受了不同的外科手术治疗急性和慢性胰腺炎。胰十二指肠切除术的两个病例在外部机构进行，未纳入本系列。结论：这是迄今为止提出的最大的胰腺胰腺机器人手术系列。机器人手术使执行困难的技术操作变得容易，从而促进了胰腺微创手术的成功。该系列的结果证明了它是可行且安全的。并发症和死亡率与开放手术相当，但具有微创手术的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号